LivaNova PLC (NASDAQ:LIVN) — Market Cap & Net Worth
Market Cap & Net Worth: LivaNova PLC (LIVN)
LivaNova PLC (NASDAQ:LIVN) has a market capitalization of $4.21 Billion ($4.21 Billion) as of September 28, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #3994 globally and #1387 in its home market, demonstrating a -1.49% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LivaNova PLC's stock price $76.63 by its total outstanding shares 54933538 (54.93 Million). Also see how large is LivaNova PLC's balance sheet for a full breakdown of the balance sheet.
LivaNova PLC Market Cap History: 2015 to 2026
LivaNova PLC's market capitalization history from 2015 to 2026. Data shows growth from $3.26 Billion to $4.21 Billion (0.84% CAGR). Also see LivaNova PLC cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
LivaNova PLC is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.64 Trillion | 0.16% | #99 of 976 |
|
NASDAQ Composite
IXIC
|
$42.21 Trillion | 0.01% | #460 of 3165 |
|
S&P Midcap 400
MID
|
$3.41 Trillion | 0.07% | #304 of 401 |
Weight: LivaNova PLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
LivaNova PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LivaNova PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check LIVN live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
2.44x
LivaNova PLC's market cap is 2.44 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.47 Billion | $1.21 Billion | -$62.80 Million | 2.04x | N/A |
| 2017 | $4.39 Billion | $1.01 Billion | -$25.10 Million | 4.34x | N/A |
| 2018 | $5.02 Billion | $1.11 Billion | -$189.40 Million | 4.54x | N/A |
| 2019 | $4.14 Billion | $1.08 Billion | -$157.64 Million | 3.82x | N/A |
| 2020 | $3.64 Billion | $934.24 Million | -$348.82 Million | 3.89x | N/A |
| 2021 | $4.80 Billion | $1.04 Billion | -$135.82 Million | 4.64x | N/A |
| 2022 | $3.05 Billion | $1.02 Billion | -$86.25 Million | 2.99x | N/A |
| 2023 | $2.84 Billion | $1.15 Billion | $17.55 Million | 2.46x | 161.99x |
| 2024 | $2.54 Billion | $1.25 Billion | $63.23 Million | 2.03x | 40.23x |
| 2025 | $3.38 Billion | $1.39 Billion | -$242.50 Million | 2.44x | N/A |
Competitor Companies of LIVN by Market Capitalization
Companies near LivaNova PLC in the global market cap rankings as of September 28, 2026. Review LivaNova PLC (LIVN) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to LivaNova PLC by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #129 globally with a market cap of $176.13 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Stryker Corporation (NYSE:SYK): Ranked #240 globally with a market cap of $104.47 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #129 | Abbott Laboratories | NYSE:ABT | $176.13 Billion | $101.29 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $88.64 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #240 | Stryker Corporation | NYSE:SYK | $104.47 Billion | $272.36 |
LivaNova PLC Historical Marketcap From 2015 to 2026
Between 2015 and today, LivaNova PLC's market cap moved from $3.26 Billion to $ 4.21 Billion, with a yearly change of 0.84%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $4.21 Billion | +24.54% |
| 2025 | $3.38 Billion | +32.87% |
| 2024 | $2.54 Billion | -10.49% |
| 2023 | $2.84 Billion | -6.84% |
| 2022 | $3.05 Billion | -36.47% |
| 2021 | $4.80 Billion | +32.05% |
| 2020 | $3.64 Billion | -12.22% |
| 2019 | $4.14 Billion | -17.54% |
| 2018 | $5.02 Billion | +14.45% |
| 2017 | $4.39 Billion | +77.72% |
| 2016 | $2.47 Billion | -24.25% |
| 2015 | $3.26 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 28th, 2026 the market cap of LivaNova PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.21 Billion USD |
| MoneyControl | $4.21 Billion USD |
| MarketWatch | $4.21 Billion USD |
| marketcap.company | $4.21 Billion USD |
| Reuters | $4.21 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About LivaNova PLC
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessor… Read more